Table S3.
Prognostic value of ABCC5 protein expression for the overall survival in univariate and multivariate analyses by Cox regression
| Covariant | Univariate analysis
|
Multivariate analysis
|
||||
|---|---|---|---|---|---|---|
| Exp (B) | 95% CI | P-value | Exp (B) | 95% CI | P-value | |
| ABCC5 protein | 4.735 | 2.002–11.200 | <0.001 | 4.101 | 1.531–10.986 | 0.005 |
| Gleason score | 2.319 | 1.213–4.435 | 0.011 | 2.363 | 1.280–4.364 | 0.006 |
| Preoperative PSA | 1.231 | 0.993–1.526 | 0.058 | |||
| Age | 2.319 | 0.765–7.027 | 0.137 | |||
| Angiolymphatic invasion | 1.325 | 0.976–1.798 | 0.071 | |||
| Surgical margin status | 1.231 | 0.810–1.872 | 0.331 | |||
| PCa stage | 3.129 | 1.248–7.845 | 0.015 | 2.175 | 1.471–3.218 | <0.001 |
| Lymph node metastasis | 1.334 | 0.701–2.539 | 0.380 | |||
| Seminal vesicle invasion | 1.729 | 0.754–3.965 | 0.196 | |||
Abbreviations: PCa, prostate cancer; PSA, prostate-specific antigen.